Global Gene Therapy Market to Grow by $4.61 Billion During 2023-2027
The gene therapy market is projected to grow by $4.61 billion from 2023 to 2027, with a CAGR of 19.91%. This growth is attributed to increasing special drug designations, benefits of gene therapy, and rising chronic diseases prevalence.
The market report analyzes key areas including market size, trends, growth drivers, and challenges, covering around 25 vendors. The report segments the market by therapy areas like oncology, CNS, and rare diseases, along with delivery modes and geography.
Key vendors include Adaptimmune Therapeutics (ADAP) and Orchard Therapeutics (ORTX), among others.
- Projected market growth of $4.61 billion from 2023 to 2027.
- CAGR of 19.91% indicates strong potential for investment.
- Increasing prevalence of chronic diseases boosts market demand.
- None.
The gene therapy market is forecasted to grow by
The report on the gene therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in special drug designations, benefits associated with gene therapy, and increasing prevalence of chronic diseases.
The gene therapy market is segmented as below:
- By Therapy Area
- Oncology
- CNS
- Ophthalmology
- Rare diseases
- Others
By Delivery Mode
- In vivo
- Ex vivo
By Geography
North America Europe Asia - Rest of World (ROW)
This study identifies the growing research in gene therapy for CVDs and orphan diseases as one of the prime reasons driving the gene therapy market growth during the next few years. Also, rapid growth potential in developing economies and rise in clinical pipeline for gene therapy will lead to sizable demand in the market.
The report on the gene therapy market covers the following areas:
- Gene therapy market sizing
- Gene therapy market forecast
- Gene therapy market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gene therapy market vendors that include Abeona Therapeutics Inc.,
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Key Topics Covered:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Therapy Area
7 Market Segmentation by Delivery Mode
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
A selection of companies mentioned in this report includes
- Abeona Therapeutics Inc.
Adaptimmune Therapeutics plc - Adverum Biotechnologies Inc.
- Amgen Inc.
- Astellas Pharma Inc.
- Biogen Inc.
- bluebird bio Inc.
- Editas Medicine Inc.
- ElevateBio
- F.
Hoffmann La Roche Ltd. - Generation Bio Co.
- Gilead Sciences Inc.
- Novartis AG
Orchard Therapeutics Plc - Poseida Therapeutics Inc.
- Sangamo Therapeutics Inc.
Sibiono GeneTech Co. Ltd. - Syncona Ltd.
- uniQure NV
- Voyager Therapeutics Inc.
For more information about this report visit https://www.researchandmarkets.com/r/4dccns
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For
For GMT Office Hours Call +353-1-416-8900
Fax (outside
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/global-gene-therapy-market-to-grow-by-4-61-billion-during-2023-2027--301770431.html
SOURCE
FAQ
What is the projected growth of the gene therapy market from 2023 to 2027?
What is the expected CAGR for the gene therapy market?
What are the key vendors in the gene therapy market?
What are the main drivers of growth in the gene therapy market?
